Aggregation pattern and factorial analysis of cardiovascular risk factors included in the metabolic syndrome in a Spanish non-diabetic population : the VIVA study *
暂无分享,去创建一个
M. J. | G. Rojo-Martínez | C. Brotons | R. Gabriel | M. Serrano-Ríos | S. Vega | J. Gómez-Gerique | J. Fernández-Carreira | A. Segura | Cabello | M. Alonso | J. Parra | Cabello | Muñiz J
[1] R. Eckel,et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.
[2] J. Shaw,et al. Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[3] M. A. Royo-Bordonada,et al. Riesgos asociados a la dieta occidental y al sedentarismo: la epidemia de obesidad , 2006 .
[4] Vera Regitz-Zagrosek,et al. Gender differences in the metabolic syndrome and their role for cardiovascular disease , 2006, Clinical Research in Cardiology.
[5] V. Fuster,et al. MDGs: chronic diseases are not on the agenda , 2005, The Lancet.
[6] E. Alegrı́a,et al. Prevalencia del síndrome metabólico en población laboral española: registro MESYAS , 2005 .
[7] M. J. Medrano,et al. Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales , 2005 .
[8] A. Biggeri,et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. , 2004, Diabetes care.
[9] S. Haffner,et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.
[10] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[11] L. Majem,et al. Prevalencia de la obesidad en España: resultados del estudio SEEDO 2000 , 2003 .
[12] P. Nilsson,et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. , 2002, Diabetes & metabolism.
[13] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[14] K. Matthews,et al. Changes in Cardiovascular Risk Factors During the Perimenopause and Postmenopause and Carotid Artery Atherosclerosis in Healthy Women , 2001, Stroke.
[15] P. Poulsen,et al. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins , 2001, Diabetologia.
[16] P. Wahl,et al. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. , 2000, American journal of epidemiology.
[17] S. Grundy,et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.
[18] PäiviLempiäinen,et al. Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men , 1999 .
[19] Ralph B D'Agostino,et al. Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.
[20] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[21] I Cikes,et al. [Prevention of coronary heart disease in clinical practice]. , 1996, Lijecnicki vjesnik.
[22] L. Guize,et al. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. , 1990, International journal of epidemiology.
[23] M. Chaparro. Prevalencia de factores de riesgo vascular en la población laboral española. , 2006 .
[24] J. Marrugat,et al. Estimacin del riesgo coronario en Espaa mediante la ecuacin de Framingham calibrada , 2003 .
[25] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.